Why Access to Leading Cancer Centers Has Not Changed Glioblastoma Outcomes – WeTrials
Vijay Agarwal/ alpheusmedical.com

Why Access to Leading Cancer Centers Has Not Changed Glioblastoma Outcomes – WeTrials

WeTrials shared on LinkedIn:

“Top hospital, same outcome. Why? Glioblastoma

Neurosurgeon Dr. Vijay Agarwal chose to train at Duke because it has a big brain tumor center. Even there, he saw glioblastoma patients dying about as quickly as at centers without Duke’s resources. He says the disease comes after people whether they are rich or poor, and that doctors have to think about it differently to extend survival.

More on WeTrials:

General information, not medical advice. Talk with your care team about your own situation.

Some illustrations in this video are AI-generated.”

Proceed to the video attached to the post.

You can also read: GPNMB CAR-T: Targeting Glioblastoma and Its Immune Microenvironment

Why Access to Leading Cancer Centers Has Not Changed Glioblastoma Outcomes - WeTrials